FBGRX
Price
$228.74
Change
-$8.02 (-3.39%)
Updated
Dec 18 closing price
RGACX
Price
$72.40
Change
-$9.37 (-11.46%)
Updated
Dec 18 closing price
Ad is loading...

FBGRX vs RGACX

Header iconFBGRX vs RGACX Comparison
Open Charts FBGRX vs RGACXBanner chart's image
Fidelity Blue Chip Growth
Price$228.74
Change-$8.02 (-3.39%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R3
Price$72.40
Change-$9.37 (-11.46%)
VolumeN/A
CapitalizationN/A
FBGRX vs RGACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FBGRX vs. RGACX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBGRX is a StrongBuy and RGACX is a Hold.

FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 313B vs. FBGRX (72.7B). RGACX pays higher dividends than FBGRX: RGACX (0.25) vs FBGRX (0.00). FBGRX was incepted earlier than RGACX: FBGRX (37 years) vs RGACX (23 years). RGACX is a more actively managed with annual turnover of: 31.00 vs. FBGRX (19.00). FBGRX has a lower initial minimum investment than RGACX: FBGRX (0) vs RGACX (250). FBGRX annual gain was more profitable for investors over the last year : 36.95 vs. RGACX (18.53). FBGRX return over 5 years is better than : 121.00 vs. RGACX (45.13).
FBGRXRGACXFBGRX / RGACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence37 years23 years-
Gain YTD36.92118.315202%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets72.7B313B23%
Annual Yield % from dividends0.000.25-
Returns for 1 year36.9518.53199%
Returns for 3 years33.744.13816%
Returns for 5 years121.0045.13268%
Returns for 10 years245.4371.87342%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGL4.810.15
+3.22%
NGL Energy Partners LP
CSPI17.990.51
+2.92%
CSP
ADNT17.60-0.01
-0.06%
Adient plc
FWONA85.52-0.66
-0.77%
Liberty Media Corp
RLMD0.36-0.03
-6.97%
Relmada Therapeutics